Hallervorden-Spatz Disease

Hallervorden-Spatz disease, also known as pantothenate kinase-associated neurodegeneration, is a rare neurodegenerative disease associated with iron accumulation in the brain. Here is the latest research.

March 25, 2020

Intellectual Disability, Falls and Gait Disturbances: A Misdiagnosis

European Journal of Case Reports in Internal Medicine
Noel Lorenzo VillalbaAbrar-Ahmad Zulfiqar
May 16, 2019

Novel PANK2 mutation discovered among South East Asian children living in Thailand affected with pantothenate kinase associated neurodegeneration

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Kullasate SakpichaisakulObjoon Trachoo
April 13, 2019
Comment / Editorial

Disease-specific patterns of basal ganglia neuronal activity in Neurodegeneration with Brain Iron Accumulation type I (NBIA-1)

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Verity M McClellandJean-Pierre Lin
October 2, 2019
Comment / Editorial
Open Access

Rhythmic Tongue Thrusting: A Useful Clinical Sign

Pediatric Neurology
Bhanudeep SinganamalaLokesh Saini
July 3, 2019
Comment / Editorial

Drug reduces excess iron in ultra-rare neurodegenerative disease

Nature Reviews. Neurology
Sarah Lemprière
April 2, 2020
Open Access

Idiopathic brain calcification in a patient with hereditary hemochromatosis

BMC Neurology
Stefania ScarliniElena Corradini
March 8, 2020
Open Access

NBIA: a network-based integrative analysis framework - applied to pathway analysis

Scientific Reports
Tin NguyenSorin Draghici
May 28, 2020
Open Access

Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration

International Journal of Molecular Sciences
Paolo SantambrogioSonia Levi
July 30, 2019

Prognostic significance of the PANK family expression in acute myeloid leukemia

Annals of Translational Medicine
Yan LiuLin Fu
March 1, 2020
Open Access

A novel way to synthesize pantothenate in bacteria involves β-alanine synthase present in uracil degradation pathway

MicrobiologyOpen
Mariana López-SámanoAlejandro García-de Los Santos
February 12, 2020
Open Access

Natural history and genotype-phenotype correlation of pantothenate kinase-associated neurodegeneration

CNS Neuroscience & Therapeutics
Xuting ChangYe Wu
October 4, 2019

Status dystonicus: management and prevention in children at high risk

Acta Bio-medica : Atenei Parmensis
Alessandro Iodice, Francesco Pisani

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/hallervorden-spatz-disease/645ff355-143a-4c4d-b65e-2e18ca89bd08